News & insights
Perspectives from the intersection of science, natural products, responsible development, and global health.
Reset Health shares perspectives on the science, infrastructure, policy, and partnerships shaping the responsible development of iboga-derived and natural-product therapeutics.
In January 2026, stakeholders from Gabon and abroad gathered in Libreville around a central question: as international interest in iboga and ibogaine accelerates, how should this emerging field develop—and who should participate in shaping it?
By Reset Health · January 20, 2026 · 7 min read
Read Article
As interest in iboga grows, reliable characterization of complex botanical materials will be essential to reproducible science and responsible development.
June 18, 2026 · 5 min read
Read Article
Local scientific capacity is not a charitable addition. It is infrastructure that enables countries of origin to generate knowledge, build agency, and participate meaningfully in development.
May 2, 2026 · 8 min read
Read Article
Credible botanical science requires more than analytical testing. Every material needs a verifiable history connecting its source, identity, handling, transformation, and quality data.
April 9, 2026 · 7 min read
Read ArticleExplore by topic
Our editorial programme follows the systems required to develop natural-product medicines responsibly.
Our perspective
Natural-product biotechnology sits at the intersection of science, manufacturing, ecology, culture, policy, and economics.
Reset Health Insights explores those connections and the infrastructure required to develop medicines responsibly from the source.
Stay connected
Receive occasional updates on Reset Health's science, development programs, partnerships, events, and perspectives.
